BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31569199)

  • 21. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
    Wen QJ; Yang Q; Goldenson B; Malinge S; Lasho T; Schneider RK; Breyfogle LJ; Schultz R; Gilles L; Koppikar P; Abdel-Wahab O; Pardanani A; Stein B; Gurbuxani S; Mullally A; Levine RL; Tefferi A; Crispino JD
    Nat Med; 2015 Dec; 21(12):1473-80. PubMed ID: 26569382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.
    Abbà C; Campanelli R; Catarsi P; Villani L; Abbonante V; Sesta MA; Barosi G; Rosti V; Massa M
    PLoS One; 2019; 14(8):e0220189. PubMed ID: 31369569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
    Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
    J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow].
    He Y; Meng HX; Zhang YG; Hou SF; Wang H; Huang Y; Li Q; Han JL; Qiu LG; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1398-402. PubMed ID: 19099652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.
    Hu Z; Ramos CEB; Medeiros LJ; Zhao C; Yin CC; Li S; Hu S; Wang W; Thakral B; Xu J; Verstovsek S; Lin P
    Hum Pathol; 2019 Mar; 85():290-298. PubMed ID: 30447300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
    Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
    Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential NOD/SCID mouse engraftment of peripheral blood CD34+ cells and JAK2V617F clones from patients with myeloproliferative neoplasms.
    Fung TK; Cheung AM; Kwong YL; Liang R; Leung AY
    Leuk Res; 2010 Oct; 34(10):1390-4. PubMed ID: 20170959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.
    Barosi G
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):129-40. PubMed ID: 25189724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
    Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
    Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
    Gleitz HFE; Dugourd AJF; Leimkühler NB; Snoeren IAM; Fuchs SNR; Menzel S; Ziegler S; Kröger N; Triviai I; Büsche G; Kreipe H; Banjanin B; Pritchard JE; Hoogenboezem R; Bindels EM; Schumacher N; Rose-John S; Elf S; Saez-Rodriguez J; Kramann R; Schneider RK
    Blood; 2020 Oct; 136(18):2051-2064. PubMed ID: 32726410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
    Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
    Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells.
    Fujiyama S; Amano K; Uehira K; Yoshida M; Nishiwaki Y; Nozawa Y; Jin D; Takai S; Miyazaki M; Egashira K; Imada T; Iwasaka T; Matsubara H
    Circ Res; 2003 Nov; 93(10):980-9. PubMed ID: 14525810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly efficient retroviral gene transfer into immortalized CD34(-) cells and organ distribution after transplantation into NOD/SCID mice.
    Thalmeier K; Huss R
    Cytotherapy; 2001; 3(4):245-51. PubMed ID: 12171712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of monocytes generated from haematopoietic CD34(+) stem cells from bone marrow of colon cancer patients.
    Stec M; Baran J; Szatanek R; Mytar B; Lenart M; Czupryna A; Szczepanik A; Siedlar M; Zembala M
    Cancer Immunol Immunother; 2013 Apr; 62(4):705-13. PubMed ID: 23180014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells.
    Schipper LF; Brand A; Fibbe WE; Van Hensbergen Y
    Stem Cells; 2012 May; 30(5):988-96. PubMed ID: 22378601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N; Ma DD; Nevell DF; Arthur C
    Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
    Spampinato M; Giallongo C; Romano A; Longhitano L; La Spina E; Avola R; Scandura G; Dulcamare I; Bramanti V; Di Rosa M; Vicario N; Parenti R; Li Volti G; Tibullo D; Palumbo GA
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.
    Giraudier S; Chagraoui H; Komura E; Barnache S; Blanchet B; LeCouedic JP; Smith DF; Larbret F; Taksin AL; Moreau-Gachelin F; Casadevall N; Tulliez M; Hulin A; Debili N; Vainchenker W
    Blood; 2002 Oct; 100(8):2932-40. PubMed ID: 12351405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.